Evidence map›Paper›PMID 30291269›Full record

ArticleScientific reports2018

Real-time Brain Tumor imaging with endogenous fluorophores: a diagnosis proof-of-concept study on fresh human samples.

Fanny Poulon, Johan Pallud, Pascale Varlet, Marc Zanello, Fabrice Chretien, Edouard Dezamis, Georges Abi-Lahoud, François Nataf, Baris Turak, Bertrand Devaux and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Towards Optical Biopsy in Glioma Surgery.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fanny PoulonIMNC Laboratory, UMR 8165-CNRS/IN2P3, Paris-Saclay university, 91405, Orsay, France.
Johan PalludNeurosurgery Department, Sainte-Anne Hospital, Paris, France.
Pascale VarletNeuropathology Department, Sainte-Anne Hospital, Paris, France.
Marc ZanelloIMNC Laboratory, UMR 8165-CNRS/IN2P3, Paris-Saclay university, 91405, Orsay, France.
Fabrice ChretienNeuropathology Department, Sainte-Anne Hospital, Paris, France.
Edouard DezamisNeurosurgery Department, Sainte-Anne Hospital, Paris, France.
Georges Abi-LahoudNeurosurgery Department, Sainte-Anne Hospital, Paris, France.
François NatafNeurosurgery Department, Sainte-Anne Hospital, Paris, France.
Baris TurakNeurosurgery Department, Sainte-Anne Hospital, Paris, France.
Bertrand DevauxNeurosurgery Department, Sainte-Anne Hospital, Paris, France.
Darine Abi HaidarIMNC Laboratory, UMR 8165-CNRS/IN2P3, Paris-Saclay university, 91405, Orsay, France. abihaidar@imnc.in2p3.fr.ORCID http://orcid.org/0000-0003-1740-4979

Funding

Institut National de la Santé et de la Recherche Médicale (National Institute of Health and Medical Research) N°CP201401Institut National de la Santé et de la Recherche Médicale (National Institute of Health and Medical Research) PC 201601
6 · The paper itself

Abstract

The primary line of therapy for high-grade brain tumor is surgical resection, however, identifying tumor margins in vivo remains a major challenge. Despite the progress in computer-assisted imaging techniques, biopsy analysis remains the standard diagnostic tool when it comes to delineating tumor margins. Our group aims to answer this challenge by exploiting optical imaging of endogenous fluorescence in order to provide a reliable and reproducible diagnosis close to neuropathology. In this study, we first establish the ability of two-photon microscopy (TPM) to discriminate normal brain tissue from glioblastomas and brain metastasis using the endogenous fluorescence response of fresh human brain sample. Two-photon fluorescence images were compared to gold standard neuropathology. "Blind" diagnosis realized by a neuropathologist on a group of TPM images show a good sensitivity, 100%, and specificity, 50% to discriminate non tumoral brain tissue versus glioblastoma or brain metastasis. Quantitative analysis on spectral and fluorescence lifetime measurements resulted in building a scoring system to discriminate brain tissue samples.

Indexed as

AdultAgedBrainBrain NeoplasmsFemaleGlioblastomaHumansLongitudinal StudiesMaleMicroscopy, Fluorescence, MultiphotonMiddle AgedOptical ImagingProof of Concept StudyProspective Studies

Identifiers

PMID30291269
PMCPMC6173695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.